Related Experiment Video
Updated: Apr 14, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Treat to target in psoriatic arthritis-evidence, target, research agenda
Laura C Coates1, Philip S Helliwell
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK, l.c.coates@leeds.ac.uk.
Abstract:
This article summarises the evidence on treating to target (T2T) in psoriatic arthritis (PsA). The evidence from the recent European League Against Rheumatism (EULAR) literature search in SpA is reviewed. This article found no studies in SpA in 2011 which compared a T2T approach against standard care in a randomised controlled trial (RCT). One of the issues raised in PsA is what target to use. The minimal disease activity (MDA) criteria were developed specifically for PsA and have been validated in observational and interventional cohorts. These have now been utilised in the Tight Control of PsA (TICOPA) study comparing T2T to standard care in early PsA providing the first evidence that T2T in PsA can improve outcomes. To translate this into clinical practice in PsA, patient education and feasibility are key. Future research must address the optimal therapies to be used within a T2T framework which will need to take subtype of PsA into account.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

